Streetbeat News

Products Services

BKYI

BIO-key International, Inc. (NASDAQ:BKYI) announced a $1.5 million two-year, pre-paid software subscription order from a long-term financial services customer for its biometric identification technology. This agreement, which anticipates about 12% annual growth in users, builds on eight years of strong client enrollment growth. The technology enhances client identification security for over 25 million clients. Approximately 90% of the contract's value is for subscription fees for the existing client base, with the remainder for expected client growth.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 2:00 pm

TSLA

Tesla, Inc. (TSLA) shares dropped in premarket trading due to rumors of declining electric vehicle demand in China, a crucial market for Tesla. Sales data indicated a decrease in Tesla's EV sales in China, with 8,200 units sold in the week of Feb 5-18, down from 10,600 units the previous week. Analyst Gordon Johnson from GLJ Research highlighted the sales drop and reduced first-quarter delivery estimates by TroyTeslike due to production issues. Johnson remains bearish on Tesla, predicting that EV manufacturing will prove unprofitable by 2024.

Portfolio Pulse from Shanthi Rexaline

February 20, 2024 | 1:59 pm

LQR

LQR House Inc. (NASDAQ:LQR), a niche ecommerce platform specializing in the spirits and beverage industry, announced a significant expansion into the UK market through a ~$1.35M purchase order for SWOL Tequila from Access Fulfillment. This marks the company's first UK-based partnership, highlighting its global brand growth ambitions and positive customer reception.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:58 pm

AAPL

META

Mark Zuckerberg praised Meta Platforms Inc's (NASDAQ:META) Quest 3 for its value and superior experience over Apple's Vision Pro, highlighting issues with the latter's screen brightness and comfort. Meta's stock has seen a significant recovery, with a 447% increase from its November 2022 low, indicating strong investor confidence. Despite a 2.21% drop after the closing bell on February 16, Meta's year-to-date stock performance remains strong with a 36% increase.

Portfolio Pulse from Zaheer Anwari

February 20, 2024 | 1:54 pm

AZN

AstraZeneca Plc's Tagrisso, in combination with chemotherapy, received FDA approval for treating certain lung cancers, showing significant improvement in patient outcomes. Additionally, AstraZeneca and Daiichi Sankyo's marketing application for datopotamab deruxtecan was accepted by the FDA for treating nonsquamous NSCLC, demonstrating a significant improvement in progression-free survival.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 1:54 pm

PXDT

Pixie Dust Technologies, Inc. (NASDAQ:PXDT), in collaboration with MAEDA Corporation and Accenture Japan Ltd., announced the development of the Rebar Inspection System. This technology, leveraging Pixie Dust's KOTOWARI™ spatial data platform, captures still images from a distance, significantly reducing shooting time by 80% compared to traditional methods. It integrates 360-degree video and Building Information Modeling (BIM) for efficient construction management, particularly in reinforcing bar arrangement inspections. The system aims to streamline operational efficiency, reduce workloads, and is expected to be commercialized soon with plans for a nationwide rollout within MAEDA Corporation by April 2024.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:53 pm

CASA

Casa Systems (NASDAQ:CASA) has developed a cloud-native Access Gateway Function (AGF) solution, successfully deployed on Amazon Web Services (AWS), to enhance wireless wireline convergence (WWC) in hybrid cloud environments. This breakthrough allows service providers to reduce redundant network components, lowering capital and operational expenses. The solution, integrating with Amazon Elastic Kubernetes Service (Amazon EKS) Anywhere, offers seamless service continuity across various networks, optimizing network infrastructure, simplifying management, and improving customer experience with potential for significant cost savings.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:50 pm

ALSN

Allison Ventures, the venture capital arm of Allison Transmission, has made a strategic investment in Niron Magnetics, a company specializing in sustainable non-rare earth permanent magnets. This investment aims to advance clean energy solutions and reduce reliance on critical materials. Niron Magnetics' technology, which avoids the use of rare earth elements, is set to revolutionize the magnet industry and support the global shift towards electrification in the mobility industry.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:48 pm

NUWE

Nuwellis is set to announce clinical data at the upcoming Technology and Heart Failure Therapeutics Conference, potentially impacting its stock.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:48 pm

CRL

Charles River Laboratories International, Inc. (NYSE:CRL) has partnered with Pluristyx Inc. to expand its portfolio with high-quality embryonic stem (ES) cells and induced pluripotent stem cells (iPSCs). This collaboration aims to accelerate therapeutic development by providing Charles River with unique stem cell lines for research. Pluristyx's offerings, including its proprietary FailSafe safety-switch technology, will be distributed by Charles River, enhancing its position as a leader in supplying human-derived biomaterials for drug discovery and cell therapy development.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:45 pm